Sort
48,018 grants matching “immunotherapy”
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
$663,998Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
$663,998Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
$663,998Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Optimizing immunoradiotherapy for HNSCC
$663,994Joseph A Califano · University Of California, San Diego · R01 · FY2025 · CA
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
$663,989Jennifer D Wu · Northwestern University At Chicago · R01 · FY2023 · CA
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
$663,989Jennifer D Wu · Northwestern University At Chicago · R01 · FY2025 · CA
Targeting posttranslational modifications of CD73 in TNBCs
$663,953Yong Wan · Emory University · R01 · FY2022 · CA
IL-27R signaling as a negative regulator of innate and adaptive anti-cancer immunity in hepatocellular carcinoma
$663,926Ekaterina Koltsova · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$663,909James R. Heath · Institute For Systems Biology · U54 · FY2018 · CA
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$663,862Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2022 · CA
Cancer Chemotherapy Training Program
$663,811Sloan-Kettering Institute For Cancer Res · T32 · FY2005 · CA
Guinea pig model for TB vaccine evaluations
$663,727Colorado State University-Fort Collins · R01 · FY2004 · AI
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
$663,646Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments
$663,626Jennifer J Hu · University Of Miami School Of Medicine · U01 · FY2023 · CA
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection
$663,585Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2019 · AI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
$663,570M. Javad Aman · Abvacc, Inc. · R01 · FY2023 · AI
Core C: Clinical Management and Resources
$663,533Igor Puzanov · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Regulation of memory CD8 T cell development
$663,481Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2025 · AI
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns
$663,468Lyle L Moldawer · University Of Florida · R01 · FY2020 · HD
Combining immunotherapy with molecularly targeted radiation therapy
$663,343Lawrence Fong · University Of California, San Francisco · R01 · FY2023 · CA
Tregulatory cell-mediated suppression of tumor elimination by NK cells and CD4 T cells
$663,340David H Raulet · University Of California Berkeley · R01 · FY2025 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
$663,338Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2022 · CA
Understanding IDH mutant gliomas
$663,335Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$663,313Vaccine Research Institute Of San Diego · R01 · FY2003 · AI
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$663,194Donald F Hunt · University Of Virginia · R37 · FY2007 · AI